US4910224A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of modifying the lipid structure and function of cell membranes and pharmaceutical compositions for use therein
Assignee: Medeva Ltd
•
Filing: 1987-02-13
•
Granted: 1990-03-20
•
Expires: 2007-02-13
Abstract
Abstract The invention is concerned with the use of certain fatty acids and inhibitors of an enzyme in effecting modifications to the lipid structure of cell membranes. The invention also relates to the formulation of pharmaceutical compositions and medicaments and to such products per se; to the treatment of a variety of clinical and veterinary disorders associated with a lowering of the saturation index of cell membranes, including malignancies, viral disorders and AIDS; and to the use of the active materials of the invention in the relief of pain. The active principals in the present invention are saturated fatty acids having from 12 to 28 carbon atoms in the alkyl chain, e.g. stearic acid, or pharmaceutically acceptable derivatives thereof; and inhibitors of the enzyme DELTA -9 desaturase, e.g. sterculic acid and malvalic acid or pharmacologically active derivatives or analogues thereof.
Inventors
- 👤 Nagy A. Habib
- 👤 Christopher B. Wood
- 👤 Kosta Apostolov
- 👤 William R. Barker
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 23:43
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/21; A61K31/215; A61K31/22; A61K31/23; A61K31/185; A61K31/19; A61K31/20; A61P; A61P31/00; A61P31/12; A61P35/00
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
62 words
A composition for the modification of the lipid structure of cell membranes and for elevation of the ratio of saturated to unsaturated lipids therein as indicated by the Saturation Index, said composition containing as an essential active ingredient, at least one compound selected from the group consisting of stearic and iodostearic acid in a form suitable for parenteral, rectal or subdermal administration.
Claim 2
Dependent Claim
62 words
A composition for the modification of the lipid structure of cell membranes and for elevation of the ratio of saturated to unsaturated lipids therein as indicated by the Saturation Index, said composition containing as an essential active ingredient, at least one compound selected from the group consisting of stearic and iodostearic acid in a form suitable for parenteral, rectal or subdermal administration.
Claim 3
Dependent Claim
14 words
The composition according to claim 1 wherein said essential active ingredient is stearic acid.
Claim 4
Dependent Claim
15 words
The composition according to claim 1 wherein said essential active ingredient is an iodostearic acid.
Claim 5
Independent Claim
51 words
The method for raising the Saturation Index in patients having clinical conditions where the status of the lipid ratio in the cellular membranes shows reduced Saturation Index levels which method comprises the steps of administering to such patients by subdermal, rectal or parenteral routes, effective amounts of stearic or iodostearic acid.
Claim 6
Independent Claim
51 words
The method for raising the Saturation Index in patients having clinical conditions where the status of the lipid ratio in the cellular membranes shows reduced Saturation Index levels which method comprises the steps of administering to such patients by subdermal, rectal or parenteral routes, effective amounts of stearic or iodostearic acid.
Claim 7
Independent Claim
44 words
The method of providing analgesia in those painful clinical conditions showing a reduced Saturation Index which comprises the steps of administering by parenteral, rectal or subdermal routes, an effective amount of stearic acid or an iodostearic acid to patients requiring analgesia for such conditions.
Claim 8
Independent Claim
44 words
The method of providing analgesia in those painful clinical conditions showing a reduced Saturation Index which comprises the steps of administering by parenteral, rectal or subdermal routes, an effective amount of stearic acid or an iodostearic acid to patients requiring analgesia for such conditions.
Claim 9
Dependent Claim
22 words
The method according to claim 5 where said conditions include benign and malignant growths, viral infections and the painful side-effects of AIDS.
Claim 10
Dependent Claim
24 words
The method according to claim 4 where said stearic acid or said iodostearic acid is administered in unit doses via a pharmaceutically acceptable vehicle.
References Cited (Backward Citations)
GB989554A
Cited
GB1280244A
Cited
US3741204A
Cited
US3805776A
Cited
US3856976A
Cited
GB1440386A
Cited
US3993775A
Cited
GB1506563A
Cited
US4097602A
Cited
GB1582992A
Cited
GB2012162A
Cited
US4302447A
Cited
US4273763A
Cited
US4388324A
Cited
EP0078434A1
Cited
EP0037175A1
Cited
GB2090529A
Cited
US4386072A
Cited
EP0071357A1
Cited
GB2104907A
Cited
EP0087864A2
Cited
GB2134782A
Cited
JPS645007A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-03-19 | 1993-09-18 | 1994-03-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-03-19 | 1997-09-18 | 1998-03-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-03-19 | 2001-09-18 | 2002-03-20 | $7700.00 | Window Closed / Lapsed |